相关临床试验
14
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2012
已完成
7
50.0%
招募中
7
50.0%
暂无批准数据
- Wandercraft has launched a groundbreaking clinical trial for its Personal Exoskeleton technology, designed to provide hands-free walking independence for individuals with severe mobility impairments. - The trial is being conducted at the James J. Peters VA Medical Center in the Bronx, with plans to expand to the Kessler Institute for Rehabilitation in New Jersey. - Building on their FDA-cleared Atalante X platform, the new Personal Exoskeleton system adapts to users' movements in real-time and enables walking across various surfaces without crutches or walkers.
• The European healthcare sector is experiencing rapid growth in AI-focused startups, with approximately 7,754 healthcare companies incorporating AI technology across the continent. • Leading AI biotech firms like Owkin and Qureight are partnering with major pharmaceutical companies to accelerate drug development and improve clinical trial efficiency through advanced data analytics. • AI applications in healthcare span from exoskeleton development for paralyzed patients to reproductive medicine and clinical data analysis, with companies focusing on patient care improvement and drug discovery optimization.
